arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

SI-BONE, Inc.

SIBN Health Care Medical/Dental Instruments
$16.71
Today
as of Jul 22, 16:54 ET
Last 30 days +8.37% Jun 12 → Jul 22
$14.90 $15.69 $16.49 $17.28 $18.07 Jun 12 Jun 22 Jun 29 Jul 08 Jul 15 Jul 22
Open
$15.11
High
$15.45
Low
$14.89
Volume
$376,599
Avg Vol
$546,645
Mkt Cap
$759M
P/E (TTM)
—
Beta
—
52w High
$21.89
52w Low
$11.48
Div Yield
—
Shares Out
$44M

Recent Press Releases & News last 60 days · 2 items

Jun 3 · 13:55 Zacks
Bears are Losing Control Over Si-Bone (SIBN), Here's Why It's a 'Buy' Now
Jun 1 · 13:55 Zacks
Wall Street Analysts Predict a 71.13% Upside in Si-Bone (SIBN): Here's What You Should Know

Overview

52-week range
$11
$22
50% of range
Avg surprise (last 3)
+35.0%
Avg reaction (last 2)
-1.8%
50% positive
Latest IV / EM
91%
EM ±20.8% · $18 · Aug 21

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.30$-0.25$-0.20$-0.15$-0.10 Actual $-0.30Actual $-0.25Actual $-0.27Actual $-0.22Actual $-0.16Actual $-0.15Est $-0.24Actual $-0.14Est $-0.19Actual $-0.11Actual $-0.10Est $-0.17 JunSepMarJunSepMar/2025Jun/2025SepMar/2026
Revenue vs Net Income Revenue Net income
$-9M$-8M$-7M$-6M$-5M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Mon May 11, 2026Mar/2026 $-0.10 $-0.17 +41.2% +33.3% -5.4% earnings
Tue Sep 30, 2025Sep 2025 $-0.11 — — — — financials
Mon Aug 4, 2025Jun/2025 $-0.14 $-0.19 +26.3% — — earnings
Mon May 5, 2025Mar/2025 $-0.15 $-0.24 +37.5% — +1.9% earnings
Mon Sep 30, 2024Sep 2024 $-0.16 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.22 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.27 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.25 — — — — financials
Fri Jun 30, 2023Jun 2023 $-0.30 — — — — financials

Upcoming

DateFiscalTimeEPS EstLY EPSYoY %Δ
Mon Aug 3, 2026Jun/2026OTHER -$0.15-$0.14 -7.1%

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue————————
Cost of revenue$11M—$10M$10M$10M—$8M$8M
Gross profit$42M—$39M$39M$38M—$32M$32M
Operating income$-5M—$-5M$-7M$-7M—$-8M$-10M
Net income$-4M—$-5M$-6M$-7M—$-7M$-9M
EPS (diluted)$-0.10—$-0.11$-0.14$-0.15—$-0.16$-0.22

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$34M$42M$26M$34M$41M$35M$30M$26M
Inventory$36M$34M$36M$34M$30M$27M$26M$23M
Total current assets$215M$216M$211M$207M$204M$208M$204M$202M
Total assets$243M$239M$234M$231M$227M$230M$227M$224M
Long-term debt$36M$36M$36M$36M$35M$35M$36M$36M
Total liabilities$64M$61M$62M$61M$60M$63M$62M$59M
Total equity$179M$178M$172M$170M$167M$167M$165M$165M

Implied volatility — last 90 days

38%51%64%77%90% Jun 12 — IV 38% · EM ±3.9%Jun 19 — IV 67% · EM ±14.8%Jun 22 — IV 79% · EM ±16.4%Jun 23 — IV 61% · EM ±12.5%Jun 24 — IV 53% · EM ±10.6%Jun 25 — IV 45% · EM ±8.8%Jun 26 — IV 41% · EM ±7.8%Jun 29 — IV 44% · EM ±7.8%Jun 30 — IV 57% · EM ±9.8%Jul 01 — IV 48% · EM ±8.0%Jul 02 — IV 41% · EM ±6.6%Jul 03 — IV 42% · EM ±6.6%Jul 06 — IV 46% · EM ±6.4%Jul 07 — IV 44% · EM ±5.8%Jul 08 — IV 48% · EM ±6.1%Jul 09 — IV 47% · EM ±5.6%Jul 10 — IV 41% · EM ±4.6%Jul 13 — IV 50% · EM ±4.2%Jul 14 — IV 63% · EM ±4.6%Jul 15 — IV 74% · EM ±4.3%Jul 16 — IV 88% · EM ±3.7%Jul 20 — IV 76% · EM ±18.0%Jul 21 — IV 74% · EM ±17.3%Jul 22 — IV 91% · EM ±20.8%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,162.23-0.1%
JNJ
Johnson & Johnson
$601.7B $255.02-0.2%
ABBV
AbbVie Inc.
$447.7B $256.20+1.1%
MRK
Merck & Company, Inc.
$307.2B $127.47-0.0%
PM
Philip Morris International Inc
$300.4B $195.00+0.3%
NVS
Novartis AG
$293.4B $152.73-0.2%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in